Red Vascular Technologies, INC
We take the COMPLEXITY out of the COMPLEX
- Stage Prototype Ready
- Industry Medical Devices and Equipment
- Location Tampa, FL, USA
- Currency USD
- Founded February 2014
- Employees 3
- Incorporation Type C-corp
- Website redvascular.com
Company Summary
Red Vascular Technologies, Inc is involved in the treatment of "Complex" Aortic Aneurysms with 6 disruptive patents. Complex AAA/TAA involve the origins of the major Aortic Branches (Renal or Carotid arteries). These patients are now subject to surgical intervention with higher procedural complications and mortality. Stent Graft treatment AAA/TAA is the Gold Standard. Our simplified systems improve patient safety and decrease complications, .
Team
-
Myles Douglas, MD, PhDFounder/ CEO/
Myles Douglas, MD, PhD, has more than 20 years of experience in clinical medicine, surgery, medical device design. He was a founder and the lead inventor of the original Endologix disruptive aneurysm treatment system. which allowed Endologix to progress from concept to commercial product in less than two years, saving patients’ lives and generating significant revenue within that time and attaining a 20% market share.
-
Co-Founder
Red Vascular Technology’s Co-founder James W. Hill, JD, MD. has more than twenty years of experience in clinical medicine, surgery, and intellectual property. Dr. Hill is a valuable member of the team. His intellectual property input will assist Red Vascular progress rapidly as well. His large experience
in the medical device arena is diverse and significant. -
Board Member
Dennis brings over 35 years of relevant Healthcare experience.
Dennis served as the President of Teleflex Medical Devices for 17 years and served as the COO and CEO International for DaVita Healthcare Partners for 18 years
Advisors
-
T. PhamUnconfirmedCardioMedUnconfirmedMedical Device ProsUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.